{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:39:39Z","timestamp":1772627979443,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bcp.2018.07.044","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T01:48:14Z","timestamp":1533174494000},"page":"524-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition"],"prefix":"10.1016","volume":"155","author":[{"given":"J.","family":"Garrido-Mesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Algieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodr\u00edguez-Nogales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Utrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chueca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Rodr\u00edguez-Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Garrido-Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.07.044_b0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0891-5849(02)00853-5","article-title":"Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease","volume":"33","author":"Pavlick","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.07.044_b0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1556\/EuJMI.1.2011.4.6","article-title":"The distinct roles of MMP-2 and MMP-9 in acute DSS colitis","volume":"1","author":"Heimesaat","year":"2011","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2018.07.044_b0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005176-200309000-00018","article-title":"Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis","volume":"37","author":"Berrebi","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bcp.2018.07.044_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/iub.1374","article-title":"Keeping bugs in check: the mucus layer as a critical component in maintaining intestinal homeostasis","volume":"67","author":"Faderl","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2018.07.044_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2018.07.044_b0030","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2018.07.044_b0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3748\/wjg.v22.i3.1078","article-title":"Role of antibiotics for treatment of inflammatory bowel disease","volume":"22","author":"Nitzan","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2018.07.044_b0040","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.07.044_b0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1874467210801010068","article-title":"Immunomodulatory properties of antibiotics","volume":"1","author":"Tauber","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.07.044_b0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.07.044_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.07.044_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2010.10.004","article-title":"Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action","volume":"63","author":"Griffin","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.07.044_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.taap.2009.02.026","article-title":"Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases","volume":"237","author":"Huang","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2018.07.044_b0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2010.12.011","article-title":"The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties","volume":"63","author":"Garrido-Mesa","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"2011","key":"10.1016\/j.bcp.2018.07.044_b0075","first-page":"1891","article-title":"The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice","volume":"82","author":"Garrido-Mesa","year":"1917","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.07.044_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.phrs.2015.04.005","article-title":"A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii","volume":"97","author":"Garrido-Mesa","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.07.044_b0085","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/gut.2003.030205","article-title":"Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn\u2019s disease and ulcerative colitis","volume":"53","author":"Franchimont","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2018.07.044_b0090","doi-asserted-by":"crossref","first-page":"e13607","DOI":"10.1371\/journal.pone.0013607","article-title":"Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon","volume":"5","author":"Wang","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2018.07.044_b0095","doi-asserted-by":"crossref","first-page":"34561","DOI":"10.1038\/srep34561","article-title":"Identification of TLR2\/TLR6 signalling lactic acid bacteria for supporting immune regulation","volume":"6","author":"Ren","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.07.044_b0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/gut.2005.065888","article-title":"Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn\u2019s disease","volume":"54","author":"van Heel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2018.07.044_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ibd.21691","article-title":"MicroRNAs in inflammatory bowel disease","volume":"18","author":"Pekow","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2018.07.044_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni0311-195","article-title":"Epithelial cell microRNAs in gut immunity","volume":"12","author":"Goto","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.07.044_b0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.07.044_b0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni.1994","article-title":"Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk","volume":"12","author":"Biton","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.07.044_b0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/srep00574","article-title":"TLR9 is important for protection against intestinal damage and for intestinal repair","volume":"2","author":"Rose","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.07.044_b0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12865-015-0069-0","article-title":"MicroRNA signatures differentiate Crohn\u2019s disease from ulcerative colitis","volume":"16","author":"Schaefer","year":"2015","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bcp.2018.07.044_b0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/1056-8719(95)00001-X","article-title":"Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid","volume":"33","author":"Wallace","year":"1995","journal-title":"J. Pharmacol. Toxicol. Methods."},{"key":"10.1016\/j.bcp.2018.07.044_b0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of chronic inflammation and ulceration in the rat colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.07.044_b0145","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/13503","article-title":"The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis","volume":"5","author":"Qiu","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2018.07.044_b0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2105-9-386","article-title":"The metagenomics RAST server \u2013 a public resource for the automatic phylogenetic and functional analysis of metagenomes","volume":"9","author":"Meyer","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.bcp.2018.07.044_b0155","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.bcp.2018.07.044_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bcp.2018.07.044_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pmic.201000273","article-title":"Proteomic analysis of the anti-inflammatory action of minocycline","volume":"11","author":"Dunston","year":"2011","journal-title":"Proteomics"},{"issue":"169","key":"10.1016\/j.bcp.2018.07.044_b0170","first-page":"5308","article-title":"Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn\u2019s disease","volume":"1950","author":"Bamias","year":"2002","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2018.07.044_b0175","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0016-5085(00)70362-3","article-title":"Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice","volume":"118","author":"Madsen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.07.044_b0180","first-page":"1207","article-title":"Reduced microbial diversity in inflammatory bowel diseases","volume":"55","author":"Ott","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2018.07.044_b0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/1574-6941.12442","article-title":"Unique and shared responses of the gut microbiota to prolonged fasting: a comparative study across five classes of vertebrate hosts","volume":"90","author":"Kohl","year":"2014","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.bcp.2018.07.044_b0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JCM.01500-13","article-title":"Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease","volume":"52","author":"Wang","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bcp.2018.07.044_b0195","article-title":"Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2018.07.044_b0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/d5030627","article-title":"Untangling the genetic basis of fibrolytic specialization by lachnospiraceae and ruminococcaceae in diverse gut communities","volume":"5","author":"Biddle","year":"2013","journal-title":"Diversity"},{"key":"10.1016\/j.bcp.2018.07.044_b0205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nrd1857","article-title":"Tigecycline","volume":"4","author":"Wenzel","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2018.07.044_b0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cell.2007.02.048","article-title":"An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling","volume":"129","author":"Fukao","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.07.044_b0215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nature06607","article-title":"Regulation of progenitor cell proliferation and granulocyte function by microRNA-223","volume":"451","author":"Johnnidis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.07.044_b0220","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1073\/pnas.0810909106","article-title":"Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals","volume":"106","author":"Bazzoni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2018.07.044_b0225","doi-asserted-by":"crossref","first-page":"G781","DOI":"10.1152\/ajpgi.00055.2013","article-title":"Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10","volume":"304","author":"Leung","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2018.07.044_b0230","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2015.00193","article-title":"Cryopreserved IL-4-treated macrophages attenuate murine colitis in an integrin \u03b27-dependent manner","author":"Leung","year":"2015","journal-title":"Mol. Med. Camb. Mass."},{"key":"10.1016\/j.bcp.2018.07.044_b0235","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1053\/j.gastro.2009.12.041","article-title":"In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice","volume":"138","author":"Hunter","year":"2010","journal-title":"Gastroenterology"},{"issue":"194","key":"10.1016\/j.bcp.2018.07.044_b0240","first-page":"364","article-title":"Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages","volume":"1950","author":"Reyes","year":"2015","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2018.07.044_b0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35006097","article-title":"Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1","volume":"404","author":"Gu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.07.044_b0250","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood-2012-12-472589","article-title":"miR-142 keeps CD4+ DCs in balance","volume":"121","author":"Belz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.07.044_b0255","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3748\/wjg.v20.i12.3223","article-title":"Trefoil factors in inflammatory bowel disease","volume":"20","author":"Aamann","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2018.07.044_b0260","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ecco-jcc\/jjw103","article-title":"Clinical effects of a topically applied toll-like receptor 9 agonist in active moderate-to-severe ulcerative colitis","volume":"10","author":"Atreya","year":"2016","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.bcp.2018.07.044_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MIB.0000195389.11645.ab","article-title":"Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases","volume":"12","author":"Pierik","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2018.07.044_b0270","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Rakoff-Nahoum","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2018.07.044_b0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOG.0b013e32832b20bf","article-title":"Antibiotics and probiotics in inflammatory bowel disease: why, when, and how","volume":"25","author":"Prantera","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2018.07.044_b0280","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.bcp.2018.07.044_b0285","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2018.07.044_b0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17460441.2013.744746","article-title":"Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders","volume":"8","author":"Geldenhuys","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bcp.2018.07.044_b0295","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.201600161","article-title":"Multitarget drug discovery and polypharmacology","volume":"11","author":"Bolognesi","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bcp.2018.07.044_b0300","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Child Health Epidemiology Reference Group of WHO and UNICEF, Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2018.07.044_b0305","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:56:38Z","timestamp":1751777798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218303137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":61,"alternative-id":["S0006295218303137"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.044","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}